Immune response to measles vaccine in 6 month old infants in Papua New Guinea

Tropical Medicine and International Health

Volumn 14, Issue 2, 2009, Pages 167-173

  Kurubi, Jonah ^b   Vince, John ^b   Ripa, Paulus ^b   Tefuarani, Nakapi ^b   Riddell, Michaela ^c   Duke, Trevor ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Immunization; Infants; Measles; Papua New Guinea; Vaccination schedule

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; MEASLES; VACCINE;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; DOSE RESPONSE; DRUG DOSE SEQUENCE; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; GROUPS BY AGE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PAPUA NEW GUINEA; SEROCONVERSION; STATISTICAL SIGNIFICANCE;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; MALE; MEASLES VACCINE; MEASLES VIRUS; PAPUA NEW GUINEA;

EID: 60349084283     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02214.x     Document Type: Article

References (26)

1. Aaby P, Anderson M, Sodemann M et al. (1993) Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ 307, 1308 1311.
2. Aaby P, Samb B, Simondon F et al. (1995) Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311, 481 485.
3. Anonymous (2005) Seroconversion rates and measles antibody titres induced by measles vaccination in Latin American children six to 12 months of age. Reviews of Infectious Diseases 5, 596 605.
4. Chen RT, Markowitz L, Albrecht P, Stewart JA Mofenson LM (1990) Measles antibody: re-evaluation of protective titres. Journal of Infectious Diseases 162, 1036 1042.
5. Cutts FT, Grabowsky M Markowitz LE (1995) The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals 23, 95 106.
6. Dick B, Smith T Kipps A (1975) A minimum age for measles vaccination to coloured children. South African Medical Journal 49, 1951 1954.
7. Duke T (2003) The crisis of measles and the need to expand the ways of delivering the EPI in PNG. Papua New Guinea Medical Journal 46, 1 7.
8. Gans HA, Arvin AM, Galinus J et al. (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at 6 months. JAMA 280, 527 532.
9. Gans H, Yasukawa L, Rinki M et al. (2001) Immune responses to measles and mumps vaccination of infants at 6, 9 and 12 months. Journal of Infectious Diseases 184, 817 826.
10. Goncalves G, Cutts F, Forsey T Andrade HR (1999) Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. Revista do Instituto de Medicina Tropical de Sao Paulo 41, 21 26.
11. Halsey NA, Boulos R, Mode F et al. (1985) Responses to measles vaccination in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. New England Journal of Medicine 29, 544 549.
12. Helfand RF, Witte D, Fowlkes A et al. (2008) Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. Journal of Infectious Diseases 198, 1 9.
13. Johnson CE, Nalin DR, Chui LW et al. (1994) Measles immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Pediatria 93, 939 944.
14. Kourouma K, Konde MK, Diallo MP et al. (1992) Vaccination against measles at 6 months of age. Annales de Pediatrie (Paris) 39, 566 571.
15. Kumar ML, Johnson CE, Chui LW et al. (1998) Immune response to measles vaccine in 6-month infants of measles seronegative mothers. Vaccine 16, 2047 2051.
16. Martins CL, Garly M-L, Bale C et al. (2008) Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. British Medical Journal 337, 339343.
17. Metintas S, Akgum Y, Arslantas D, Kalyoncu C Ucar B (2002) Decay of maternally derived measles antibodies in central Turkey. Public Health 116, 50 54.
18. Mgone J, Mgone C, Duke T, Frank D Yeka W (2000) Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. Papua New Guinea Medical Journal 43, 90 97.
19. Perry R, Mmiro F, Ndugwa C Semba RD (2000) Measles infection in HIV-infected African infants. Annals of the New York Academy of Sciences 918, 377 380.
20. Rogers S, Sanders RC Alpers MP (1991) Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age. Journal of Tropical Medicine and Hygiene 94, 88 91.
21. Sakatoku H, Nakano T, Arai S Afari EA (1994) Antibody responses to measles vaccination in rural Ghanaian infants. Journal of Tropical Paediatrics 40, 291 293.
22. Samb B, Aaby P Whittle H (1995) Serological status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatric Infectious Disease Journal 14, 203 209.
23. Schnorr JJ, Cutts FT, Wheeler JG et al. (2001) Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 19, 1503 1510.
24. Shann F (2002) Non-specific effects of vaccines in developing countries: we need evidence about the effects of vaccines on mortality from all causes. British Medical Journal 321, 1423 1424.
25. Tischer A, Gassner M, Richard J-L et al. (2007) Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunoflourescence and plaque neutralization. Journal of Clinical Virology 38, 204 209.
26. Vidvashankar C (2002) Optimal age for measles vaccination. Journal of the Indian Medical Association 100, 24 26.